Search Results

Juvenile myelomonocytic leukemia (JMML)

JMML is an uncommon blood cancer that is most commonly diagnosed in infants and children younger than  years old.

Chronic myelomonocytic leukemia (CMML)

CMML is a rare blood cancer that has overlapping features of two other types of blood cancers: MDS and MPNs. CMML is rare in children.

Unraveling the Cellular and Molecular Origins of B-cell Acute Lymphoblastic Leukemia in Down syndrome

Children with Down Syndrome (DS) have a -fold increased risk of Acute Lymphoblastic Leukemia (). We aim to identify the cells of origin in and defin…

FDA Approves Vyxeos for Secondary Acute Myeloid Leukemia in Children

DUBLIN, March , - Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced that the U.S. Food and Drug Administration (FDA) approved a revised label for Vyx…

The Leukemia & Lymphoma Society Joins CancerX Inaugural Project

The Leukemia & Lymphoma Society (LLS) has joined on as a proud partner of CancerX’s inaugural project, “Advancing Digital Innovation to Improve Equit…

BRAF inhibition as an alternative to chemotherapy in the treatment strategy of hairy cell leukemia

Hairy cell leukemia (HCL) is very sensitive to chemotherapy, whose toxicity to the bone marrow and the immune system is however concerning. We have es…

Pluripotent Stem Cell-derived CAR-T and CAR-NK Cells for Immunotherapy of Leukemia and Lymphoma

Cytotoxic cells of the immune system, including T and NK cells, can be targeted to seek out and destroy leukemia, lymphoma and myeloma cells by engine…

Suggested Reading -Cancer Crossings: A Brother, His Doctors, and the Quest for a Cure to Childhood Leukemia

Cancer Crossings: A Brother, His Doctors, and the Quest for a Cure to Childhood Leukemia by Tim WendelILR Press, , Pages, Paperback and KindleISBN: -…

The Leukemia & Lymphoma Society’s Light The Night Events Lead the Charge Against Blood Cancer

The Leukemia & Lymphoma Society’s Light The Night Events Lead the Charge Against Blood Cancer.

T cells with native and chimeric receptors against multiple tumor targets for acute myeloid leukemia

Adoptive T cell therapies for acute myeloid leukemia face numerous hurdles such as limited target antigens, immunosuppressive tumor environment as wel…

Therapeutic targeting of T-cell acute lymphoblastic leukemia using an AKR1C3-activated prodrug

acute lymphoblastic leukemia () is an aggressive malignancy that is exceptionally difficult to cure after relapse. We have previously shown that expr…

Leukemia Survivor Named National ‘Visionary of the Year’ Redefining What’s Possible After Diagnosis

The Leukemia & Lymphoma Society (LLS) Announces National Winners of Evolutionary ‘Visionaries of the Year’ Campaign; Funds Raised Will Help LLS Improv…

Leveraging Susceptible Populations and Unique Resources in a Pathway to Prevention of Childhood Acute Lymphoblastic Leukemia

The focus of my research is to understand the causes and origins of acute lymphoblastic leukemia (ALL). We use a approach: ) conducting epidemiologi…

The Leukemia & Lymphoma Society Receives $17 Million from the Mike and Sofia Segal Family Foundation to Accelerate Progress in the Treatment of Chronic Myelomonocytic Leukemia

Mike and Sofia Segal, who immigrated to the U.S. from Ukraine in , lead foundation that supports overlooked and underfunded causes, including rare di…

Update on Acute Lymphoblastic Leukemia

Advances in Acute Myeloid Leukemia

Advances in Chronic Myeloid Leukemia

Hairy cell leukemia (HCL) treatment

HCL is usually slow growing, and not all newly diagnosed patients require immediate treatment, which consists of either standard of care or clinical t…

Juvenile myelomonocytic leukemia (JMML) diagnosis

Diagnosing JMML usually involves ruling out other similar diseases such as CMML  and CML, especially if your child is older than years.

Juvenile myelomonocytic leukemia (JMML) treatment

Two JMML treatment protocols are widely used: stem cell transplantation and drug therapy. Without treatment, JMML progresses rapidly.

Chronic Lymphocytic Leukemia (CLL) Diagnosis

An accurate diagnosis for CLL is important in order to estimate the disease’s progression and determine the appropriate treatment.

Living with Hairy Cell Leukemia

PresentationClick Here

Update on Acute Lymphoblastic Leukemia

Topics Covered We invite you to learn more about: Current and emerging therapies for Acute Lymphoblastic Leukemia (ALL) Treatment side effects an…

Living with Hairy Cell Leukemia

Presentation Click Here Topics Covered We invite you to learn more about: Diagnosis and current treatment options for hairy cell leukemia …

Advances in Chronic Myeloid Leukemia

[Click here to enlarge.] Topics Covered We invite you to learn more about: …